Current Drug Targets - Infectious Disorders

Editorial [Hot Topic: HIV Vaccine Discovery and Development (Guest Editor: Julia L. Hurwitz)]
pp. 81-83(3)
Author: Hurwitz, J. L.

The HIV Pandemic: A Forgotten Crisis?
pp. 85-86(2)
Authors: Madzikanga, M.; Kangwende, A.; Pfumojena, J.; Slobod, K. S.; Hurwitz, J. L.

Fundamental Immunology and What it Can Teach us About HIV Vaccine Development
pp. 87-93(7)
Authors: Mitchison, N. A.; Sattentau, Q.

Antibodies: Can They Protect Against HIV Infection?
pp. 95-111(17)
Authors: Mc Cann, C. M.; Song, R. J.; Ruprecht, R. M.

CD8+ T-cells: Are They Sufficient to Prevent, Contain or Eradicate HIV-1 Infection?
pp. 113-119(7)
Authors: Brown, S. A.; Hurwitz, J. L.; Zhan, X.; Doherty, P. C.; Slobod, K. S.

Differentiation of CD8 T Cells in Response to Acute and Chronic Viral Infections: Implications for HIV Vaccine Development
pp. 121-129(9)
Authors: Miller, J. D.; Masopust, D.; Wherry, E. J.; Kaech, S.; Silvestri, G.; Ahmed, R.

Inactivated- or Killed-Virus HIV/AIDS Vaccines
pp. 131-141(11)
Author: Sheppard, H. W.

Application of the Polyvalent Approach to HIV-1 Vaccine Development
pp. 143-156(14)
Authors: Hurwitz, J. L.; Slobod, K. S.; Lockey, T. D.; Wang, S.; Chou, Te-Hui W.; Lu, S.

HIV-1: The Confounding Variables of Virus Neutralization
pp. 157-170(14)
Authors: Nara, P. L.; Lin, G.

HIV-1 Envelope Evolution and Vaccine Efficacy
pp. 171-177(7)
Author: Mosier, D. E.

Predicting the Potential Public Health Impact of Disease-Modifying HIV Vaccines in South Africa: The Problem of Subtypes
pp. 179-192(14)
Authors: Blower, S. M.; Bodine, E. N.; Grovit-Ferbas, K.

Non-Human Primate Models for AIDS Vaccine Research
pp. 193-201(9)
Author: Hu, Shiu-Lok